68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models |
|
Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma |
|
Algorithmes d'apprentissage et logiciels pour la statistique, avec applications à la bioinformatique. |
|
[ALK, a key gene in the pathogenesis of neuroblastoma]. |
|
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome |
|
The ALK receptor in sympathetic neuron development and neuroblastoma. |
|
BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells |
|
Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics |
|
Caractérisation des amplifications génomiques et des mécanismes de surexpression de la protéine MYCN dans le neuroblastome |
|
Characterization of amplicons in neuroblastoma: High-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes |
|
Characterization of GAPCenA, a GTPase activating protein for Rab6, part of which associates with the centrosome |
|
Characterization of novel Rab6-interacting proteins involved in endosome-to-TGN transport |
|
Characterization of rearrangements involving the ALK gene reveals a novel truncated form associated with tumor aggressiveness in neuroblastoma |
|
Cholinergic switch associated with morphological differentiation in neuroblastoma |
|
Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN. |
|
The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking |
|
Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization |
|
Crystal structures of the small G protein Rap2A in complex with its substrate GTP, with GDP and with GTPgammaS. |
|
Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis. |
|
ETUDE DE LA PROTEINE HUMAINE RAP2, APPARENTEE AUX PRODUITS DES ONCOGENES |
|
[Genetic alterations in neuroblastoma and their usefulness for clinical management] |
|
Genomic characterization of pediatric liver tumors and identification of molecular biomarker of therapeutic response.. |
|
Germline gain-of-function mutations of ALK disrupt central nervous system development. |
|
Germline mutations of the paired-like homeobox 2B |
|
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. |
|
High-resolution mapping of amplicons of the short arm of chromosome 1 in two neuroblastoma tumors by microarray-based comparative genomic hybridization. |
|
HMCan-diff: a method to detect changes in histone modifications in cells with different genetic characteristics |
|
Hyperactivation of Alk induces neonatal lethality in knock-in AlkF1178L mice |
|
Identification of a specific effector of the small GTP-binding protein Rap2 |
|
In-Depth Characterization of Human Retinoblastoma Subtype 2 and Preclinical Models |
|
An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours. |
|
Interaction of a Golgi-associated kinesin-like protein with Rab6 |
|
Learning algorithms and statistical software, with applications to bioinformatics |
|
Learning smoothing models of copy number profiles using breakpoint annotations |
|
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification |
|
Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma |
|
Molecular analysis of chromosome arm 17q gain in neuroblastoma |
|
Molecular pathogenesis of peripheral neuroblastic tumors |
|
Neuroblastome, résistance in vivo à l'irinotecan et voie de signalisation ALK |
|
The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation |
|
Overall genomic pattern is a predictor of outcome in neuroblastoma |
|
Phosphorylation of Rap1GAP during the Cell Cycle |
|
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study |
|
Preferential occurrence of chromosome breakpoints within early replicating regions in neuroblastoma |
|
Prognostic impact of gene expression-based classification for neuroblastoma. |
|
QuantumClone: Clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction. |
|
Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival. |
|
Recent insights into the biology of neuroblastoma |
|
Le récepteur à neurotrophines TrkC, un nouveau récepteur à dépendance impliqué dans la tumorigenèse du neuroblastome. |
|
Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma |
|
Regulation of the GTPase activity of the ras-related rap2 protein |
|
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations |
|
Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade |
|
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers |
|
Rôle des facteurs de transcription PHOX2B, GATA3 et HAND2 dans l'identité et l'oncogenèse du neuroblastome |
|
SegAnnDB: interactive Web-based genomic segmentation |
|
Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma |
|
Study of the human rap2 protein, related to the products of the ras proto-oncogenes. |
|
SV-Bay: structural variant detection in cancer genomes using a Bayesian approach with correction for GC-content and read mappability |
|
SVDetect: a tool to identify genomic structural variations from paired-end and mate-pair sequencing data |
|
The sympathetic nervous system: malignancy, disease, and novel functions. |
|
Les translocations chromosomiques : des modifications cellulaires à l'oncogenèse |
|
Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression |
|
Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment |
|
Use of the Two-Hybrid System to Identify Rab-Interacting Proteins |
|
VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles |
|
Variety and complexity of chromosome 17 translocations in neuroblastoma |
|
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma |
|
Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells |
|